Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/DIVISLAB stock hub

NSE/DIVISLAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/DIVISLABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.8T

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/DIVISLAB

In the news

Latest news · NSE/DIVISLAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E61.5

P25 24.9P50 32.4P75 45.7

Trailing P/E71.9

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC18.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/DIVISLAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

202

Groups with data

Currency

INR

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	10,542
Employees Change	801%
Employees Change Percent	8.22
Enterprise value	INR 1.7T
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE361B01024
Last refreshed	2026-05-10
Market cap	INR 1.8T
Price	INR 6,705
Price currency	INR
Rev Per Employee	9,783,722.25x
Sector	Healthcare
Sic	2833
Symbol	nse/DIVISLAB
Website	https://www.divislabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.39%
EV Earnings	70.58x
EV/EBIT	59.37x
EV/EBITDA	52.01x
EV/Sales	16.96x
Forward P/E	61.52x
P/B ratio	11.56x
P/E ratio	71.87x
P/S ratio	17.27x
PE Ratio10 Y	44.39x
PE Ratio3 Y	68.35x
PE Ratio5 Y	58.75x
PEG ratio	3.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	28.57%
EBITDA Margin	32.61%
Gross margin	61.65%
Gross Profit	INR 63.6B
Gross Profit Growth	22.08%
Gross Profit Growth Q	18.75%
Gross Profit Growth3 Y	7.83%
Gross Profit Growth5 Y	8.77%
Net Income	INR 24.8B
Net Income Growth	19.93%
Net Income Growth Q	-1.02%
Net Income Growth Years	1%
Net Income Growth3 Y	1.13%
Net Income Growth5 Y	5.79%
Pretax Margin	31.89%
Profit Margin	24.04%
Profit Per Employee	INR 2.4M
Profitable Years	21
Roa5y	12.42
Roe5y	18.89
ROIC	18.14
Roic5y	22.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	21.52%
Cagr15y	23.06%
Cagr1y	9.56%
Cagr20y	24.79%
Cagr3y	27.56%
Cagr5y	11.4%
Div CAGR10	11.61%
Div CAGR3	0%
Div CAGR5	8.45%
EPS Growth	19.95
EPS Growth Q	-0.99
EPS Growth Years	1
EPS Growth3 Y	1.12
EPS Growth5 Y	5.79
Revenue Growth	13.62x
Revenue Growth Q	12.29x
Revenue Growth Quarters	10x
Revenue Growth Years	2x
Revenue Growth3 Y	7.36x
Revenue Growth5 Y	9.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 32.6B
Debt	INR 900M
Debt EBITDA	INR 0.03
Debt Equity	INR 0.01
Equity	INR 154.1B
Interest Coverage	163.7
Net Cash	INR 31.7B
Net Cash By Market Cap	INR 1.78
Net Cash Growth	-11.77%
Net Debt EBITDA	INR -0.94
Net Debt Equity	INR -0.21
Tangible Book Value	INR 154.1B
Tangible Book Value Per Share	INR 581
WACC	5.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	INR 30
Dividend Years	23
Dividend Yield	0.45%
Ex Div Date	2025-07-25
Last Dividend	INR 30
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	601.87%
1Y total return	9.56%
200-day SMA	6,296.4
3Y total return	107.6%
50-day SMA	6,247.7
50-day SMA vs 200-day SMA	50under200
5Y total return	71.56%
All Time High	7,071.5
All Time High Change	-5.18%
All Time High Date	2025-07-08
All Time Low	7.75
All Time Low Change	86,416.13%
All Time Low Date	2003-03-12
ATR	131.9
Beta	0.22
Beta1y	0.37
Beta2y	0.22
Ch YTD	4.89
High	6,759
High52	7,071.5
High52 Date	2025-07-08
High52ch	-5.18%
Low	6,675
Low52	5,636.5
Low52 Date	2025-09-29
Low52ch	18.96%
Ma50ch	7.32%
Price vs 200-day SMA	6.49%
RSI	73.51
RSI Monthly	60.61
RSI Weekly	61.27
Sharpe ratio	0.37x
Sortino ratio	0.84
Total Return	0.46%
Tr YTD	4.89
Tr15y	2,147.67%
Tr1m	14.62%
Tr1w	1.29%
Tr3m	11.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 29.5B
Operating Income Growth	21.33
Operating Income Growth Q	19.88
Operating Income Growth3 Y	3.66
Operating Income Growth5 Y	4.54
Operating margin	28.57

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117,823,721%
Shares Insiders	49.05%
Shares Institutions	25.13%
Shares Out	265,468,580
Shares Qo Q	-0.02%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	279,349x
Bv Per Share	581
Ch10y	555.9
Ch15y	1,850.4
Ch1m	14.62
Ch1w	1.29
Ch1y	9.06
Ch20y	6,996
Ch3m	11.3
Ch3y	103.8
Ch5y	66.41
Ch6m	0.73
Change	0.04%
Change From Open	0.07
Close	6,702.5
Days Gap	-0.04
Depreciation Amortization	4,160,000,000
Dollar Volume	1,039,911,975
Earnings Date	2026-05-22
EBIT	INR 29.5B
EBITDA	INR 33.6B
EPS	INR 93.37
F Score	2
Fiscal Year End	March
Founded	1,990
Graham Number	1104.74679
Graham Upside	-83.52
Income Tax	INR 8.1B
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Last Split Date	2015-09-23
Last Split Type	Forward
Lynch Fair Value	INR 541
Lynch Upside	-91.93
Ma150	6,315.4
Ma150ch	6.17%
Ma20	6,388.1
Ma20ch	4.96%
Next Earnings Date	2026-05-22
Open	6,700
Payment Date	2025-09-10
Position In Range	35.71
Price Date	2026-05-08
Price EBITDA	INR 52.97
Ptbv Ratio	11.56
Relative Volume	0.57x
Revenue	103,140,000,000x
Tax By Revenue	7.85x
Tax Rate	24.63%
Tr20y	8,280.25%
Tr6m	0.73%
Volume	155,095

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/DIVISLAB dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$30.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.4%

0 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2025-07-25

Performance

NSE/DIVISLAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/DIVISLAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+25.1%

Share of float held by funds and institutions

Insider ownership

+49.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

NSE/DIVISLAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

73.5

Above 70: short-term overbought

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

0.22

Less volatile than the market

Sharpe ratio

0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/DIVISLAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/DIVISLAB stock rating?

nse/DIVISLAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/DIVISLAB analysis?

The full report lives at /stocks/nse/DIVISLAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/DIVISLAB?

The latest report frames nse/DIVISLAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/DIVISLAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.